Oncolix Inc. (fka ONCX)

[zen222]

Chart technicals are showing a confirmed bullish trend. 95% of chartists don't give a shit about the fundamentals of a company. They play the chart tech and that's pointing to another leg up. They'll buy on that alone. The share price will continue the bullish trend for the time being regardless of news.

Oncolix, Inc. with its 30 worldwide patents for Cancer treatments and multiple drugs in their pipeline (including flagship ovarian Cancer-fighting drug Prolanta having a $3 Billion market potential) reverse-merging into a debt free and low-float AEPP are the fundamentals investors are buying for.

Everyone knows fundamental catalysts beat chart technicals every time, what I think is interesting here is that we have both in AEPP. Outstanding technicals and amazing fundamentals, the total package.